Search - tctmd.com

Displaying 421 - 440 of 502

Sort: Relevancy | Date

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Jason Kahn

March 05, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

News Daily News

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Leah Lawrence

January 05, 2012

Presentation TCT 2012

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in drug-eluting stents 9-13 months after implantation: in vivo-assessment with optical coherence...

Presenter: Juan Luis Guti?rrez-Chico, Lorenz R?ber, Evelyn Regar, Takayuki Okamura, Carlo di Mario, Stephan Windecker, Gerrit-Anne van Es, Patrick W. Serruys

January 03, 2012

Presentation TCT 2012

The Nine-Month Outcomes of a Polymer-Free Drug-Eluting Stent (YUKON) Compared with Different Polymer Based Drug-Eluting Stents in Real-World Coronary Artery Lesions.

Presenter: Ted S. Trajceski, Lulzim Brovina, Zivko Petrovski, Blerim Zuna, Borce Petrovski

January 03, 2012

Presentation TCT 2012

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Presenter: Israel M. Barbash, Rebecca Torgusson, Itsik Ben-Dor, Gabriel Maluenda, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Response of Endothelial Progenitor Cells To Antiproliferative Drugs Currently Used in Drug Eluting Stents

Presenter: Hao Xu, Kytai T. Nguyen, Lance S. Terada, Eric Fuh, Joseph A. Garcia, Emmanouil S. Brilakis, Deepak L. Bhatt, Subhash Banerjee

January 03, 2012

Presentation TCT 2012

Predictors Of Adverse Cardiac Events after PCI With GENOUS EPC-Coated Stents Compared To Drug Eluting Stents

Presenter: Boris Rudenko, Anatoly Savchenko, Serdgey Tereshchenko, Olga Cherkavskaya

January 03, 2012

Presentation TCT 2012

Long-term Safety and Effectiveness of Drug Eluting Stents Compared to Bare Metal Stents in Non ST Elevation Myocardial Infarction: Findings from the Guthrie Health Off-Label...

Presenter: Sudhakar Sattur, Pam Orshaw, Judy Boura, Kishore Harjai

January 03, 2012

Presentation TCT 2012

Lipoprotein(a) level and 2-year clinical outcomes in patients in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

Presenter: Sang-Ho Park, Seung Woon Rha, A-Ra Cho, Jae Yun Kim, Hyeok-Gyu Lee, Se-Whan Lee, Won-Yong Shin, Seung-Jin Lee, Dong-Kyu Jin, Byoung Geol Choi, Amro Elnagar, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Presentation TCT 2012

Incidence of Periprocedural Myocardial Infarction Following Stent Implantation: Comparison Between First and Second Generation Drug-Eluting Stents

Presenter: Kenneth Tandjung, Mounir W. Basalus, Esther Muurman, Hans Louwerenburg, K. Gert van Houwelingen, Martin G. Stoel, Frits H. de Man, Hanneke Jansen, Jennifer Huisman, Gerard C. Linssen, Herman T. Droste, Mark B. Nienhuis, Clemens von Birgelen

January 03, 2012

Presentation TCT 2012

Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation -Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents-

Presenter: Yoshitaka Muraoka, Shinjo Sonoda, Kuninobu Kashiyama, Reo Anai, Fumihiko Kamezaki, Yuki Tsuda, Masaru Araki, Masahiro Okazaki, Yutaka Otsuji

January 03, 2012

Presentation TCT 2012

Impact of ApoB/ApoA-I ratio on two-year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

Presenter: Sang-Ho Park, Seung Woon Rha, Jae Yun Kim, A-Ra Cho, Hyeok-Gyu Lee, Se-Whan Lee, Won-Yong Shin, Seung-Jin Lee, Dong-Kyu Jin, Byoung Geol Choi, Amro Elnagar, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Presentation TCT 2012

Five Year Survival After Percutaneous Coronary Intervention With Drug Eluting Stents And Bare Metal Stents In All-Comers. A New Jersey Statewide Database Study

Presenter: Tudor Vagaonescu, Abel E. Moreyra, Yingzi Deng, Nora Cosgrove, John B. Kostis

January 03, 2012

Presentation TCT 2012

First Generation versus Newer Generation Drug-eluting Stents in Unprotected Left Main Coronary Artery Intervention

Presenter: Amro Elnagar, Seung Woon Rha, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin Oh Na Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 03, 2012

Presentation TCT 2012

Everolimus-eluting stents show no stent thrombosis with similar one year outcomes compared with 1st and 2nd generation drug-eluting stents for the treatment of ST-segment...

Presenter: Kyounghoon Lee, Tae Hoon Ahn, Soon Yong Suh, Woong Chol Kang, Seung Hwan Han, Eak Kyun Shin

January 03, 2012

Advertisement

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

SCAAR: Second-Generation DES Improve Hard Outcomes

DES Show Better Outcomes vs. BMS in Elderly, Though Use Declining

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in drug-eluting stents 9-13 months after implantation: in vivo-assessment with optical coherence...

The Nine-Month Outcomes of a Polymer-Free Drug-Eluting Stent (YUKON) Compared with Different Polymer Based Drug-Eluting Stents in Real-World Coronary Artery Lesions.

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Response of Endothelial Progenitor Cells To Antiproliferative Drugs Currently Used in Drug Eluting Stents

Predictors Of Adverse Cardiac Events after PCI With GENOUS EPC-Coated Stents Compared To Drug Eluting Stents

Long-term Safety and Effectiveness of Drug Eluting Stents Compared to Bare Metal Stents in Non ST Elevation Myocardial Infarction: Findings from the Guthrie Health Off-Label...

Lipoprotein(a) level and 2-year clinical outcomes in patients in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

Incidence of Periprocedural Myocardial Infarction Following Stent Implantation: Comparison Between First and Second Generation Drug-Eluting Stents

Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation -Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents-

Impact of ApoB/ApoA-I ratio on two-year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

Five Year Survival After Percutaneous Coronary Intervention With Drug Eluting Stents And Bare Metal Stents In All-Comers. A New Jersey Statewide Database Study

First Generation versus Newer Generation Drug-eluting Stents in Unprotected Left Main Coronary Artery Intervention

Everolimus-eluting stents show no stent thrombosis with similar one year outcomes compared with 1st and 2nd generation drug-eluting stents for the treatment of ST-segment...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content